Arformoterol (Brovana)

Indications


Contraindications

  • Acute Bronchospasm
    • Acute Asthma Exacerbation
    • Acute COPD Exacerbation

Pharmacology


Administration

  • INH: BID
  • Cautions
    • Use with extreme caution in patients on monoamine oxidase (MAO) inhibitors, tricyclic antidepressants, and drugs which prolong the QT interval (due to potentiation of effect of adrenergic agents on the cardiovascular system)

Adverse Effects

Cardiovascular Adverse Effects

Pulmonary Adverse Effects

  • Paradoxical Brochospasm (see Obstructive Lung Disease, [[Obstructive Lung Disease]]): although uncommon, this may occur with all β2-adrenergic receptor agonists

Other Adverse Effects

  • Increased Risk of Death in Asthma: class effect for all β2-adrenergic receptor agonists
  • Pain: occurs in 8% of cases (vs 5% of placebo-treated cases)

References

  • xxxx